Treatment resistance

What is treatment-resistant bipolar disorder?

Medications provide symptom respite and improvement in quality of life for many people with bipolar disorder. However, for some, medications do not provide adequate relief from symptoms. A broad definition of treatment resistance includes those patients whose symptoms have not responded adequately to medications, or only partially responded after four or more weeks of treatment with appropriate doses.

What is the evidence for treatment-resistant bipolar disorder?

Moderate to low quality evidence suggests non-response to antipsychotic medications in people with bipolar disorder in an acute mania phase is around 41%, and non-remission is around 65%.

Early non-response in week one and two of treatment significantly predicted non-response and non-remission in week three, regardless of antipsychotic characteristics.

April 2019

Last updated at: 4:33 am, 8th April 2019
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.